×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| AUROBINDO PHARMA LTD. | 29319.4 | 5591.3 | 28481.7 | 9.63 | 61,125 | 18.1 |
| GLENMARK PHARMACEUTICALS LTD. | 24642.63 | 3302.26 | 23949.28 | 11.7 | 57874 | 43.5 |
| BIOCON LTD. | 5984.0 | -83.0 | 5371.0 | -0.07 | 48645 | 134.0 |
Aurobindo Pharma Ltd., with Security Code 524804, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
Failed to load quarterly data. Please try again later.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | -3% |
| 3 Years: | -12% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 5% |
| 3 Years: | -14% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 10% |
| 3 Years: | 30% |
| 1 Year: | -3% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 8% |
| 3 Years: | 5% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 6% |
| 3 Years: | -1% |
| TTM: | 27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 10% |
| 3 Years: | 30% |
| 1 Year: | -3% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|